Journal of comparative effectiveness research

J Comp Eff Res · ISSN (e) 2042-6313 · 6 papers in corpus
observational 2023
doi:10.57264/cer-2023-0025 ·PMID:37212790

Aim: This largest-of-its-kind study evaluated the clinical utility of CA125 and OVA1, commonly used as ovarian tumor markers for assessing the risk of malignancy. The research focused on the ability and utility of these tests to reliably pr…

other 2023
doi:10.57264/cer-2023-0003 ·PMID:37345566

Aim: Assess the budget impact of nationwide screening for diminished ovarian reserve (OR), via anti-Müllerian hormone (AMH) levels, to the Portugal National Health System (NHS). Patients & methods: The clinical journey was determined using …

other 2021
doi:10.2217/cer-2020-0243 ·PMID:33880938

Aim: To assess health-related quality of life (HRQoL) of patients with benign gynecological disorders. Materials & methods: Prospective 2-year follow-up with the 15D HRQoL-instrument of 311 women treated in Helsinki-area hospitals in 2012-2…

observational 2020
doi:10.2217/cer-2020-0181 ·PMID:33140993

Aim: To evaluate impact of co-morbidities on opioid use in endometriosis. Patients & methods: This was a retrospective analysis of data obtained from the Symphony Health database (July 2015-June 2018), which contains medical and pharmacy cl…

nonrandomized-trial 2019
doi:10.2217/cer-2018-0124 ·PMID:30724096

AIM: To assess the cost-effectiveness of elagolix versus leuprolide acetate in women with moderate to severe endometriosis pain. METHODS: A Markov model was developed. The efficacy of leuprolide acetate was derived from statistical predict…

review 2012
doi:10.2217/cer.12.38 ·PMID:24237468

Endometriosis is a gynecological disorder defined by the presence of endometrial-like tissue outside the uterus. Several studies have found an epidemiological correlation between endometriosis and migraine, probably due to the association o…